natgillin/translations-raw huggingface dataset:
is CHF2, CF3, H, F, Cl, or R1 and R2 may be taken together with their attached ring A to form a fused ring system selected from the group consisting of naphthalenyl, isoquinolinyl, and tetrahydronaphthalenyl; provided that R2 may not be H if R1 is H; 
je CHF2, CF3, H, F, Cl, ili R1 i R2 mogu biti uzeti zajedno s prstenom A za koji su vezani da tvore spojeni prstenasti sustav odabran iz skupine koju čine naftalenil, izokinolinil, i tetrahidronaftalenil; pod uvjetom da R2 ne može biti H ukoliko R1je H;
or A1 and A2 may be taken together with their attached nitrogen to form a ring selected from the group consisting of: thiomorpholinyl, piperidinyl, pyrrolidinyl, and morpholinyl; wherein said piperidinyl, and pyrrolidinyl are optionally substituted with CF3, CH2F, CH2CH2F, C(1-2)alkyl, -CN, OH, or CH2OH, and up to three additional substituents selected from the group consisting of CH3, and F; 
tiomorfolinil, piperidinil, pirolidinil, i morfolinil; pri čemu su navedeni piperidinil, i pirolidinil proizvoljno supstituirani s CF3, CH2F, CH2CH2F, C(1-2)alkil, -CN, OH, ili CH2OH, i do tri dodatna supstituenta odabrana iz skupine koju čine CH3, i F; je SO2NA3A4, C(CF3)2OH,
is CHF2, CF3, H, F, Cl, or R1 and R2 may be taken together with their attached ring A to form a fused ring system selected from the group consisting of naphthalenyl, and isoquinolinyl; provided that R2 may not be H if R1 is H; 
je CHF2, CF3, H, F, Cl, ili R1 i R2 mogu biti uzeti zajedno s prstenom A za koji su vezani da tvore spojeni prstenasti sustav odabran iz skupine koju čine naftalenil, i izokinolinil; pod uvjetom da R2 nije H ukoliko R1 je H;
is or phenyl, wherein said phenyl is optionally substituted with R6; 
je ili fenil, pri čemu je navedeni fenil proizvoljno supstituiran s R6;
A pharmaceutical composition, comprising a compound of claim 1 and a pharmaceutically acceptable carrier. 
Farmaceutski pripravak, naznačen time što sadrži spoj prema zahtjevu 1 i farmaceutski prihvatljiv nosač.
A compound for use according to claim 11, wherein the disease is selected from the group consisting of: rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disorder, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, neutrophilic asthma, steroid resistant asthma, multiple sclerosis, systemic lupus erythematosus, and ulcerative colitis. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest odabrana iz skupine koju čine: reumatoidni artritis, psorijaza, kronična obstruktivna plućna bolest, psorijazni artritis, ankilozni spondilitis, Crohnova bolest, neutrofilna astma, astma rezistentna na steroide, multipla skleroza, sistemski eritemski lupus, i ulcerozni kolitis.
A compound for use according to claim 11, wherein the disease is rheumatoid arthritis. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest reumatoidni artritis.
A compound for use according to claim 11, wherein the disease is ulcerative colitis. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest ulcerozni kolitis.
A compound for use according to claim 11, wherein the disease is Crohn's disease. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest Crohnova bolest.
A compound for use according to claim 11, wherein the disease is multiple sclerosis. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest multipla skleroza.
A compound for use according to claim 11, wherein the disease is neutrophilic asthma. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest neutrofilna astma.
A compound for use according to claim 11, wherein the disease is steroid resistant asthma. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest astma rezistentna na steroide.
A compound for use according to claim 11, wherein the disease is psoriatic arthritis. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest psorijazni artritis.
A compound for use according to claim 11, wherein the disease is ankylosing spondylitis. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest ankilozni spondilitis.
A compound for use according to claim 11, wherein the disease is systemic lupus erythematosus. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest sistemski eritemski lupus.
A compound for use according to claim 11, wherein the disease is chronic obstructive pulmonary disorder. 
Spoj za uporabu prema zahtjevu 11, naznačen time što je bolest kronična opstruktivna bolest pluća.
A compound of claim 1 for use in a method of treating or ameliorating a syndrome, disorder or disease, in a subject in need thereof comprising administering to the subject an effective amount of a compound of claim 1 or composition or medicament thereof in a combination therapy with one or more anti-inflammatory agents, or immunosuppressive agents, wherein said syndrome, disorder or disease is selected from the group consisting of: rheumatoid arthritis, and psoriasis. 
Spoj prema zahtjevu 1 za uporabu u postupku liječenja ili ublažavanja sindroma, bolesti ili poremećaja, kod subjekta kojem je potrebno koji sadrži davanje subjektu učinkovite količine spoja prema zahtjevu 1 ili njegovog pripravka ili lijeka u kombiniranoj terapiji s jednim ili više protuupalnih sredstava, ili imunosupresiva, pri čemu je navedeni sindrom, bolest ili poremećaj odabran iz skupine koju čine, reumatoidni artritis i psorijaza.
A method for managing a dynamic address translation DAT table, characterised by the method comprising steps of: determining, by a processor, from an opcode of a machine executable instruction (401) to be executed, that the instruction is a compare and replace DAT table entry instruction, which is used to replace a valid DAT table entry with a new entry, the instruction comprising an R1 field and an R2 field, the R1 and R2 fields each designating an even-odd pair of general registers R1 and R1+1 and R2 and R2+1, and must designate an even-numbered register, wherein general register R1 is the even register of the pair and contains a first operand called the compare value, general register R1+1 is the odd register of the pair and contains a replacement value, and wherein general registers R2 and R2+1 contain addressing information such as designated-table type (DTT) and effective index into a table to locate an original second operand from a second operand memory location; and 
određivanja, procesorom, iz operacijskog koda strojno izvršive upute (401) koju treba izvršiti, da je uputa uputa o uspoređivanju i zamjeni podatka unesenog u DAT tablicu, koju se upotrebljava za zamjenu valjanog podatka unesenog u DAT tablicu novim unesenim podatkom, gdje uputa sadrži polje R1 i polje R2, gdje svako od polja R1 i R2 označuje parno-neparni par općih registara R1 i R1+1 i R2 i R2+1, te mora označavati parno numerirani registar, gdje je opći registar R1 parni registar u paru i sadrži prvi operand nazvan usporedna vrijednost, opći registar R1+1 je neparni registar u paru i sadrži zamjensku vrijednost, te gdje opći registri R2 i R2+1 sadrže informacije o adresiranju, poput označenog tabličnog tipa (DTT) i efektivnog indeksa u tablicu radi lociranja izvornog drugog operanda iz lokacije drugog operanda u memoriji; i izvršavanje, procesorom, gdje uputa sadrži:
comparing (436) the first operand and the original second operand; 
uspoređivanje (436) prvog operanda s izvornim drugim operandom;
The method of claim 1, comprising storing the original second operand into the even R1 register based on the first operand being not equal to the original second operand. 
Postupak u skladu s patentnim zahtjevom 1, naznačen time što se sastoji u spremanju izvornog drugog operanda u parni registar R1 na osnovi toga što prvi operand nije jednak izvornom drugom operandu.
The method of claim 1, wherein a translation table entry selectively cleared corresponds to lower level translation table entries associated with the original second operand. The method according to claim 1, further comprising: 
Postupak u skladu s patentnim zahtjevom 1, naznačen time što selektivno izbrisani podatak unesen u translacijsku tablicu odgovara nižerazinskim podacima unesenim u translacijsku tablicu povezanim s izvornim drugim operandom.
The method of claim 1 wherein the TLB entries cleared are limited to entries formed to translate addresses in an address space specified by the instruction. 
Postupak u skladu s patentnim zahtjevom 1, naznačen time što su izbrisani podaci uneseni u TLB ograničeni na unesene podatke formirane za prebacivanje adresa u prostor za adrese specificiran u uputi.
based on a mask field of the instruction having a first value, selectively clearing only a TLB of the processor executing the instruction of a plurality of processors of a configuration; and based on a mask field of the instruction having a second value, selectively clearing the TLB of a plurality of processors of the configuration. 
na osnovi polja maske u uputi koje ima prvu vrijednost, selektivno brisanje samo TLB u procesoru koji izvršava uputu za više procesora u konfiguraciji; i na osnovi polja maske u uputi koje ima drugu vrijednost, selektivno brisanje TLB u više procesora u konfiguraciji.
A system comprising means adapted for carrying out all the steps of the method according to any preceding method claim. 
Sustav, naznačen time što ima sredstvo prilagođeno za provođenje svih koraka postupka u skladu s bilo kojim od prethodnih patentnih zahtjeva na postupak.
A computer program comprising instructions for carrying out all the steps of the method according to any preceding method claim, when said computer program is executed on a computer system. 
Računalni program, naznačen time što sadrži upute za provođenje svih koraka postupka u skladu s bilo kojim od prethodnih patentnih zahtjeva na postupak, kada se navedeni računalni program izvršava na računalnom sustavu.
a feeding pipe (24) for feeding bulk material from the storage container (20) to a dosing container (22), 
cijev (24) za dovod rasutog materijala iz spremnika za pohranu (20) do spremnika za doziranje (22),
An apparatus according to claim 1, wherein the discharge line is a pneumatic feeding system. 
Uređaj sukladno zahtjevu 1, pri čemu isipna linija predstavlja pneumatski transportni sustav.
An apparatus according to any one of claims 1-4, wherein the dosing discharge device is a screw conveyor (26) adapted for continuously providing a predetermined volumetric amount of bulk material. 
Uređaj sukladno bilo kojem zahtjevu 1 do 4, pri čemu je ispusni uređaj za doziranje zapravo pužni transporter (26) prilagođen za stalni dovod unaprijed određene volumetrijske količine rasutog materijala.
An apparatus according to claim 5, wherein said screw conveyor (26) being adapted to provide a predetermined rotational speed in order to achieve the predetermined volumetric amount of bulk material. 
Uređaj sukladno zahtjevu 5, pri čemu je pužni transporter (26) opremljen opcijom podešavanja brzine vrtnje kako bi se dobila unaprijed određena volumetrijska količina rasutog materijala.
A method according to claim 8, whereby the discharge line is a pneumatic feeding system. 
Postupak sukladno zahtjevu 8, pri čemu isipna linija predstavlja pneumatski transportni sustav.
A method according to any of the claims 8 to 11, wherein the dosing discharge device is a screw conveyor (26) adapted for continuously providing a predetermined volumetric amount of bulk material. 
Postupak sukladno bilo kojem zahtjevu 8 do 11, pri čemu je ispusni uređaj za doziranje zapravo pužni transporter (26) prilagođen za stalni dovod unaprijed određene volumetrijske količine rasutog materijala.
A method according to any of the claims 8 to 12, wherein said screw conveyor (26) being adapted to provide a predetermined rotational speed in order to achieve the predetermined volumetric amount of bulk material. 
Postupak sukladno bilo kojem zahtjevu 8 do 12, pri čemu je pužni transporter (26) opremljen mogućnosti podešavanja brzine vrtnje kako bi se dobila unaprijed određena volumetrijska količina rasutog materijala.
the payment processor (110) is configured to send a payment authorization request text message to the mobile phone of the user (102) requesting authorization for payment of the payment request; 
procesor plaćanja (110) je konfiguriran za slanje tekstualne poruke zahtjeva za autorizaciju plaćanja mobilnom operateru (112) korisnika (102) zahtijevajući odobrenje za plaćanje zahtjeva za plaćanje;
The system of claim 1 or 2, wherein the payment authorization text message from the mobile phone of the user includes a personal identification code unique to the user. 
Sustav prema zahtjevu 1, naznačen time da tekstualna poruka autorizacije plaćanja s mobilnog telefona korisnika (102) uključuje osobni identifikacijski kod jedinstven za korisnika (102).
The system of any one of claims 1 to 4, wherein the mobile phone account of the user can is increased to include a balance for payment of goods or services from a merchant. 
Sustav prema bilo kojem od zahtjeva 1 do 3, naznačen time da se račun mobilnog telefona korisnika (102) može povećati da uključuje saldo za plaćanje roba ili usluga (105) od trgovca (104).
receiving by a payment processor (110) a payment request for goods or services (105) from a merchant (104); 
primanje od strane procesora plaćanja (110) zahtjeva za plaćanje za robe ili usluge (105) od trgovca (104);
wherein the payment request includes a mobile phone number or mobile phone account of a user; 
pri čemu račun mobilnog telefona uključuje saldo za plaćanje roba ili usluga;
sending by the payment processor (110) a payment authorization request text message to the mobile phone of the user requesting authorization for payment of the payment request; 
slanje tekstualne poruke zahtjeva za autorizaciju plaćanja od strane procesora plaćanja (110) mobilnom operateru (112) korisnika (102) zahtijevajući odobrenje za plaćanje zahtjeva za plaćanje;
if the payment authorization text message from the mobile phone of the user authorizes the payment of the payment request, paying the merchant by the payment processor (110) for the goods or services and charging the mobile phone account of the user for the payment; and 
ako tekstualna poruka autorizacije plaćanja s mobilnog telefona korisnika (102) odobrava plaćanje zahtjeva za plaćanje, izravno plaćanje trgovcu od strane procesora plaćanja (110) u ime korisnika (102) za robe ili usluge i zaduženje računa mobilnog telefona korisnika (102) za plaćanje;
The method of any one of claims 6 to 8, further comprising including in the mobile phone account of the user a prepaid balance for payment of goods or services (105) from a merchant (104). 
Metoda prema bilo kojem od zahtjeva 5 do 7, dalje sadržeći povećanje salda računa mobilnog telefona korisnika (102) koje je dovoljno za plaćanje roba ili usluga (105) od trgovca (104).
if the payment authorization text message from the mobile phone of the user authorizes the payment of the payment request, paying directly the merchant by the payment processor on behalf of the user for the goods or services and charging the mobile phone account of the user for the payment; and 
ako tekstualna poruka autorizacije plaćanja s mobilnog telefona korisnika (102) odobrava plaćanje zahtjeva za plaćanje, izravno plaćanje trgovcu od strane procesora plaćanja (110) u ime korisnika (102) za robe ili usluge i zaduženje računa mobilnog telefona korisnika (102) za plaćanje;
at least one main body (2) configured to at least partially define a portion of the partitioning wall (102), said main body (2) comprising a plurality of through openings (3) substantially identical to each other in shape and size; 
• najmanje jedno glavno tijelo (2) konfigurirano tako da definira najmanje dio pregradnog zida (102), gdje navedeno glavno tijelo (2) sadrži veći broj prolaznih otvora (3) koji su međusobno identični po obliku i veličini;
A method of making a multiparticulate composition, the method comprising: 
Način za dobivanje enteričkog premazanog multipartikularnog pripravka, koji se sastoji od:
comprises a gelatin film adhered to the core; 
proteinski podsloj je neprekidni želatinasti film;
The system of claim 8, characterized in that the solar greenhouse is the micro-pressure house, and the pressure therein is 50000 pascal. 
Sustav iz patentnog zahtjeva 8, naznačen time, da je solarni staklenik kuća s mikro tlakom, i tlak u njemu je 50000 paskala.
Roller shutter according to claim 3, characterized in that said roller (3) has octagonal cross section and in that said roller shutter is constrained so that when the roller shutter is wound up, said four laths (211, 212, 213, 214) rest on four of the eight sides of the octagon. 
Roleta u skladu s patentnim zahtjevom 3, naznačena time što navedeni valjak (3) ima osmerokutni poprečni presjek, te što je navedena roleta tako ograničena da kada je roleta namotana, navedene četiri letvice (211, 212, 213, 214) leže na četiri od osam strana osmerokuta.
Method as claimed in claim 2, characterized in that the holes (26) in the covering plate (19) are made by drilling. 
Postupak u skladu s patentnim zahtjevom 2, naznačen time što se rupe (26) u pokrovnoj ploči (19) načini bušenjem.
Method as claimed in claim 3, characterized in that the holes (26) in the covering plate (19) are drilled through the sea valves (33). 
Postupak u skladu s patentnim zahtjevom 3, naznačen time što se rupe (26) u pokrovnoj ploči (19) izbuši kroz podmorske ventile (33).
Method as claimed in claim 2, characterized in that the holes (26) in the covering plate (19) are made by flame cutting to rough diameter and grinding to final diameter. 
Postupak u skladu s patentnim zahtjevom 2, naznačen time što se rupe (26) u pokrovnoj ploči (19) načini rezanjem plamenom do grubog promjera i brušenjem do konačnog promjera.
Method as claimed in any of the preceding claims, characterized in that the supporting cradle (21) is floated below the underwater section (12) and fixed to said underwater section (12) by divers. 
Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačen time što ronioci doplutaju nosivu gondolu (21) ispod podvodnog dijela (12), te pričvrste na navedeni podvodni dio (12).
Method for assembling the thruster unit (10), characterized in that the steps of the method are executed in a reverse order to the steps of the disassembling method 1. 
Postupak sastavljanja potisne jedinice (10), naznačen time što se korake postupka provodi obratnim redoslijedom u odnosu na korake postupka rastavljanja 1.
Method as claimed in claim 1 or 14, characterized in that before starting the disassembly and/or assembly work the thruster unit (10) is made airtight with plugging equipment and the airtightness of the thruster unit (10) is secured. 
Postupak u skladu s patentnim zahtjevom 1 ili 14, naznačen time što se prije započinjanja rada na rastavljanju i/ili sastavljanju potisnu jedinicu (10) načini hermetičnom opremom za začepljivanje, te se osigura hermetičnost potisne jedinice (10).
L reuteri ATCC PTA 6475 for use in the prevention or treatment of bone loss. 
L reuteri ATCC PTA 6475 naznačen time što je za uporabu za sprječavanje ili liječenje gubitka kosti.
The composition for use according to claim 2 for use in improving bone repair after fracture. 
Pripravak za uporabu prema zahtjevu 2 naznačen time što je za uporabu za poboljšanje zarastanja kosti nakon frakture.
A pharmaceutical composition for use in a method of treating a subject having cancer comprising orally administering to the subject the pharmaceutical composition comprising a therapeutically effective amount of 5-azacytidine, wherein the composition is an immediate release composition and wherein the cancer is acute myelogenous leukemia. 
Farmaceutski pripravak za upotrebu u postupku liječenja subjekta koji ima rak koji obuhvaća oralno davanje farmaceutskog pripravka subjektu koji se sastoji iz terapeutski učinkovite količine 5-azacitidina, pri čemu pripravak je pripravak s trenutnim oslobađanjem i pri čemu je rak akutna mijelogena leukemija.
The pharmaceutical composition for use according to claim 5, wherein the composition further comprises an excipient selected from mannitol, microcrystalline cellulose, crospovidone, and magnesium stearate, or wherein the composition further comprises a permeation enhancer. 
Farmaceutski pripravak za upotrebu prema zahtjevu 5, naznačen time što pripravak nadalje sadrži pomoću tvar odabranu od manitola, mikrokristalne celuloze, krospovidona, i magnezijevog stearata, ili pri čemu pripravak nadalje sadrži pojačivač permeabilnosti.
A process for producing a recombinant Sclerotium rofsii lectin protein comprising: 
Postupak za proizvodnju rekombinantne Sclerotium rolfsii bjelančevine tipa lektin koji se sastoji od:
A method of operating a pack for holding and re-charging an e-cigarette, said pack comprising a body portion including a tube for receiving an e-cigarette, a pack battery for re-charging the e-cigarette received into said tube, and a lid attached to the body portion, where said lid can be opened to allow the e-cigarette to be received into the tube, and closed to retain the e-cigarette in the tube, said method comprising: detecting that the lid has been opened; in response to sa id detecting, initiating an active mode; and 
Postupak upravljanja pakiranjem za držanje i ponovno punjenje e-cigarete, navedeno pakiranje sadrži pakiranje s baterijom; dio tijela koji obuhvaća cijev za prihvaćanje e-cigarete; mehanizam ponovnog punjenja za ponovno punjenje e-cigarete koja je primljena u navedenu cijev korištenjem pakiranja s baterijom, pri čemu se e-cigareta može ponovno napuniti u navedenoj cijevi bez rastavljanja e-cigarete; i mehanizam za dvostruku aktivaciju koji se sastoji dva odvojena okidača koji uzrokuju da mehanizam ponovnog punjenja počne ponovno puniti e-cigaretu primljenu u navedenu cijev korištenjem pakiranja s baterijom, naznačen time što postupak sadrži: detektiranje aktivacije od strane korisnika prvog od dva navedena okidača;
Compounds of formula (I) wherein R is hydrogen or C(O)-R1, wherein R1 is a linear alkyl chain containing 2 to 5 carbon atoms, and wherein R' is a linear alkyl chain containing 3 to 6 carbon atoms or an optionally substituted aryl group or an optionally substituted heteroaryl group. 
, naznačen time što: R je C(O)-R1; je vodik ili nerazgranati alkilni lanac, koji sadrži 2 do 5 atoma ugljika; i R’ je nerazgranati alkilni lanac, koji sadrži 3 do 6 atoma ugljika ili izborno supstituirana arilna skupina ili izborno supstituirana heteroarilna skupina;
A compound for use according to claim 7, characterized in that said tumor disease includes malignant neoplasias and metastasis. A compound for use according to claim 8, characterized in that said tumor diseases are solid tumors, preferably epithelial tumors, such as prostate carcinoma; mammary carcinoma; pancreatic carcinoma; lung carcinoma; gastrointestinal tract carcinoma, such as colon carcinoma; kidney cancer; thyroid carcinoma; uterine carcinoma; adrenal carcinoma. 
Spoj, naznačen time što je namijenjen upotrebi u skladu s patentnim zahtjevom 7 ili 8, naznačen time što su navedene tumorske bolesti čvrsti tumori, po mogućnosti tumori epitela, poželjnije gdje su tumori epitela karcinom prostate; karcinom dojke; karcinom gušterače; karcinom pluća; karcinom gastrointestinalnog sustava, poput karcinoma debelog crijeva; rak bubrega; karcinom štitnjače; karcinom maternice; ili karcinom nadbubrežne žlijezde.
Pharmaceutical compositions for use according to claim 17, characterized in that said tumor diseases are solid tumors, preferably epithelial tumors, such as prostate carcinoma; mammary carcinoma; pancreatic carcinoma; lung carcinoma; gastrointestinal tract carcinoma, such as colon carcinoma; kidney cancer; thyroid carcinoma; uterine carcinoma; adrenal carcinoma. 
Farmaceutski pripravak namijenjen upotrebi u skladu s patentnim zahtjevom 17 ili 18, naznačen time što su navedene tumorske bolesti čvrsti tumori, po mogućnosti tumori epitela, poput karcinoma prostate; karcinoma dojke; karcinoma gušterače; karcinoma pluća; karcinoma gastrointestinalnog sustava, poput karcinoma debelog crijeva; raka bubrega; karcinoma štitnjače; karcinoma maternice; karcinoma nadbubrežne žlijezde.